McKesson (NYSE:MCK) traded at a new 52-week high today of $106.60. This new high was reached on below average trading volume as 683,000 shares traded hands, while the average 30-day volume is approximately 1.2 million shares.
There is potential upside of 5.3% for shares of McKesson based on a current price of $106.55 and an average consensus analyst price target of $112.25. The stock should discover initial support at its 50-day moving average (MA) of $97.36 and subsequent support at its 200-day MA of $91.76.
In the past 52 weeks, shares of McKesson have traded between a low of $76.00 and a high of $106.60 and are now at $106.55, which is 40% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.7% while the 200-day MA has risen 0.3%.
McKesson Corporation distributes pharmaceuticals, medical-surgical supplies, and and health and beauty care products throughout North America. The Company also develops, implements, and supports software that facilitates the integration of data throughout the health enterprise. In addition, McKesson offers analytic, care management, and patient solutions for payers.